Combination of | |
---|---|
Fenofibrate | Fibrate |
Simvastatin | Statin |
Clinical data | |
Trade names | Cholib |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
KEGG |
Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. [1] It contains fenofibrate and simvastatin. [1]
It was approved for use in the European Union in August 2013. [1]
Fenofibrate/simvastatin is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adults with mixed dyslipidemia to reduce triglycerides and increase HDL C levels when LDL C levels are adequately controlled with the corresponding dose of simvastatin monotherapy. [1]
{{cite journal}}
: CS1 maint: overridden setting (link)